• Business
  • Personal
  • About Us
  • Our People
  • Insights
  • Contact Us
  • Log in
header desktop background
Menu
  • Business
  • Personal
  • About Us
  • Our People
  • Insights
  • Contact Us
  • Log in
header mobile background
header mobile background
All
Articles (626)
Events (5)
News (42)
64 results for 'Healthcare'
  • PHARMA + LIFE SCIENCE Adobestock 1044274898 LR
    • Articles

    The Association of the British Pharmaceutical Industry (ABPI) has issued a policy proposal aimed at supporting the delivery of the NHS 10-Year Plan.

    13 May 2025

    The plan is built around three core shifts in care: from hospital to community, from analogue to digital, and from treatment to prevention. These shifts reference the government’s ambition to deliver economic growth through improved health outcomes.

    • Pharmaceuticals & Life Sciences
  • PHARMA + LIFE SCIENCE Adobestock 1044274898 LR
    • Articles

    NICE introduces promising improvements to the routing criteria for highly specialised technologies designed to treat rare diseases

    13 May 2025

    The newly approved routing criteria is hoped to clearly define the circumstances for when highly specialised technologies (HSTs) will be routed to the HST programme which is designed to evaluate technologies for ultra-rare debilitating conditions.

    • Pharmaceuticals & Life Sciences
  • PHARMA + LIFE SCIENCE Adobestock 1044274898 LR
    • Articles

    Sustainability - why this is now crucial for pharma business leaders?

    01 Apr 2025
    Whether your business is in early stage drug discovery and R&D or manufacturing, supply, and distribution, every part of the pharma ecosystem is now under increasing pressure to adopt sustainable practices.
    • Pharmaceuticals & Life Sciences
  • PHARMA + LIFE SCIENCE Adobestock 1044274898 LR
    • Articles

    Spending on medicines and medical devices increases but VPAG clawback reach record levels

    01 Apr 2025
    NHS spending on medicines, appliances and medical devices in England hit £19.9bn in 2023/24, with £14.6bn in branded medicine sales. However, the VPAG clawback is meanwhile expected to be an unprecedented £3.5bn in 2025, £1bn more than previously forecast
    • Pharmaceuticals & Life Sciences
  • EMPLOYMENT Adobestock 603300137
    • Articles

    Changes to immigration rules: protection of care workers and salary adjustments

    26 Mar 2025

    The recent Statement of Changes to UK Immigration Rules introduces critical updates, including protections for care workers and changes to the methods for calculating salary thresholds.

    • Employment
  • CARE HOMES Adobestock 234694432
    • Articles

    Navigating insolvency risks: directors’ duties for care home professionals

    25 Feb 2025

    Operating a care home is becoming increasingly challenging as providers navigate economic pressures, stringent regulatory requirements, and the growing demands of an ageing population.

    • Healthcare
  • 1
  • 2
  • ...
  • 11
Contact Us

Business
  • Banking & Finance
  • Charities
  • Digital & Technology
  • Education
  • Government & Public Services
  • Healthcare
  • Pharmaceuticals & Life Sciences
  • Real Estate & Infrastructure
Personal
  • Contentious Probate
  • Court of Protection
  • Family
  • Personal Immigration
  • Personal Injury
  • Probate & Estate Management
  • Residential Conveyancing
  • Wills & Trusts
About us
  • Careers
  • Diversity & Inclusion
  • Awards & Accreditations
  • Responsible Business
Locations
  • Birmingham
  • Bristol
  • Henleaze
  • London
  • Watford
    • Sitemap
      Policies & Terms
      Pay Online
      Pricing Information
      Regulatory Matters
    • Facebook
    • X
    • LinkedIn
    • Instagram
    • YouTube

    ©Veale Wasbrough Vizards LLP.
    All rights reserved.

    © Veale Wasbrough Vizards LLP. All rights reserved. VWV is a brand of Veale Wasbrough Vizards LLP, a limited liability partnership registered in England and Wales, registered number OC384033, registered office Narrow Quay House, Narrow Quay, Bristol BS1 4QA. A list of members may be inspected at the registered office. The term 'Partner' means a member of Veale Wasbrough Vizards LLP or a senior employee of equivalent standing. Veale Wasbrough Vizards LLP is authorised and regulated by the Solicitors Regulation Authority (SRA 597329). Offices in Birmingham, Bristol, London and Watford. A member of The Association of European Lawyers with representative offices throughout the EU & Central & Eastern Europe. VAT Registration number GB 172 8860 77.